|
Risk Management in Persons at
Risk for Atherosclerotic Cardiovascular Disease (Primary
Prevention)
Atherosclerosis is a
chronic progressive disease, which commences at an early
age. The
majority of acute myocardial infarctions are precipitated by
rupture of a non-flow limiting atherosclerotic plaque.
Therefore, efforts to reduce the incidence of acute
myocardial infarction should ideally commence prior to the
development of symptoms or signs of myocardial ischemia
(that is, in a primary prevention setting).
To facilitate this, we have adapted our secondary
prevention program for use in persons at risk for
atherosclerotic cardiovascular disease by virtue of the
presence of risk factors.
The basic approach to
comprehensive cardiovascular disease risk management
utilized by us for persons at risk for atherosclerotic
cardiovascular disease is summarized in Figure
2. As for our secondary prevention program, the cardiovascular
disease risk management action plan is formulated primarily
in accordance with published American Heart Association
guidelines (Tables 1 and 2).
Other key similarities and differences between the
two programs are summarized in the Figures and Tables.
In an attempt to increase
access to the program, it has been designed in a manner
which enables it to be administered in a variety of clinical
and community-based settings.
Currently, the program is administered at two local
hospitals and at a shopping mall.
Regarding the latter, shopping malls are conveniently
located, easily accessible, indoors and not subject to
adverse weather conditions, and provide a relatively safe
environment where program participants can walk for
exercise.
The program is administered
by appropriately qualified non-physician health care
professionals who are guided by a computerized patient
management and tracking system.
In view of this, and because patients are referred to
their personal physician for medication changes, the entire
program is administered without direct physician
involvement.
The case-management system
utilized by the program’s health care professionals
includes behavioral interventions derived from several
well-established behavior change models, primarily social
learning theory and the stages of change model.
Materials and messages are matched with the
participant’s stage of readiness for change.
Only on concept or skill is introduced at a time
(single concept learning theory), in an easy-to-understand
and carefully sequenced way.
At each visit to the program, the participant listens
to a 5 to 10 minute behavior modification audiotape, is
provided with an educational kit on the specific topic, and
meets with the health care professional for further
counseling and to update the participant’s individualized
lifestyle modification program.
Cognitive and behavioral processes are emphasized to
varying extents and in various ways depending upon the
participant’s stage of readiness.
Cognitive processes include: increasing knowledge,
comprehending benefits of changing a behavior, warning of
risks and consequences of not changing and empowering the
individual to take action based on internal motivation.
Participants engage in numerous self-assessment and
self-monitoring activities, including weighing the
“pros” and “cons” of changing, keeping exercise and
food diaries, completing stress and smoking logs, and
assessing self-efficacy. Behavioral processes include: counter-conditioning, enlisting
social support, using rewards, controlling stimuli and
building confidence. An
awards program recognizes individuals who make and sustain
positive changes. Group
support meetings and recreational activities provide
opportunities to involve others in the change process.
Because participants are at risk for relapse,
emphasis is given to planning for high risk situations and
dealing with and learning from slips.
The effect of the exercise,
nutrition, and combined exercise plus nutrition components
of this program on select cardiovascular disease risk
factors have been evaluated in two randomized clinical
trials. These
studies, conducted in Dallas, Texas and Savannah, Georgia
suggest that despite a substantially lower cost, the
lifestyle intervention components of our program are at
least as effective as 12-weeks of traditional cardiac
rehabilitation (Table
3).
Confluence of Primary
and Secondary Prevention
The dichotomization of
prevention interventions into primary and secondary
categories is based upon the identification of symptoms or
signs of atherosclerotic cardiovascular disease.
As eluded to above, a meta-analysis of the pathology
of acute myocardial infarction has shown that approximately
68% of acute myocardial infarctions arise from the rupture
of lesions in coronary arteries that are less than 50%
stenosed and approximately 86% of acute myocardial
infarctions arise from the rupture of lesions in coronary
arteries that are less than 70% stenosed.
Coronary artery stenoses of less than 70% are
typically non-flow-limiting, asymptomatic, and challenging
to identify. Clearly,
the distinction between primary and secondary prevention of
atherosclerotic cardiovascular disease is somewhat
arbitrary. Moreover,
as technological advances leading to earlier detection of
unstable non-flow-limiting atherosclerotic stenoses evolve,
the dividing line between primary and secondary prevention
will become less clear.
In view of this and because
many of the interventions comprising cardiovascular risk
management are similar for primary and secondary prevention,
a natural synergy has evolved between the two programs
outlined above. Once
clinically stable, patients with atherosclerotic
cardiovascular disease are now often triaged from our
“secondary” prevention program to our “primary”
prevention program for long-term lifestyle intervention and
follow-up, with referral back to our “secondary”
prevention program as warranted by their clinical status.
Because of the lower cost and more frequent
patient-staff interactions associated with our “primary”
prevention program, this has enhanced the cost-effectiveness
of our “secondary” prevention program.
We anticipate that the synergy and overlap between
the two programs will continue to evolve with time.
About the Author
Dr.
Gordon is the medical director of the Center for Heart
Disease Prevention at the St. Joseph’s/Candler Health
System, Savannah, Georgia.
He is a past Vice-President of the American
Association for Cardiovascular and Pulmonary Rehabilitation
and currently serves on the Board of Trustees of the
American College of Sports Medicine.
|